News

Filter by Category

Filter by Program

Filter by Date

January 8, 2014

EMA updates guidance for Qualification of Novel Methodologies for Drug Development

January 3, 2014

A discussion with Dr. Anne Rowzee of the Center for Drug Evaluation and Research, US FDA about patient input into the design of st

December 2, 2013

September 10, 2013

C-Path cosponsors workshop on combination drug development for Alzheimer’s disease Combination therapy development has been

August 13, 2013

July 1, 2013

May 24, 2013

The Predictive Safety Testing Consortium (PSTC) led by the Critical Path Institute (C-Path) and the Safer and Faster Evidence-base

February 21, 2013

The Board of Directors of the Critical Path Institute (C-Path) announced today that Martha Brumfield, Ph.D., has been named interi

November 29, 2012

Combination therapy development has been successful in other life-threatening diseases in part because collaborative approaches we

November 2, 2012